GlobalGov › Czech Republic › Award

PHOENIX lékárenský velkoobchod, s.r.o. won Czechia – Antihypertensives – Léčivé přípravky k léčbě plicní arteriální hypertenze (PAH) - XII. - Treprostinil from Institut klinické a experimentální medicíny

Institut klinické a experimentální medicíny · Czech Republic government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$3.9M
Award Value
November 5, 2024
Award Date
Awarded
Status

Award Overview

PHOENIX lékárenský velkoobchod, s.r.o. was awarded Czechia – Antihypertensives – Léčivé přípravky k léčbě plicní arteriální hypertenze (PAH) - XII. - Treprostinil by Institut klinické a experimentální medicíny in Czech Republic, tracked by GlobalGov. The award is valued at $3.9M. It was awarded on November 5, 2024. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeePHOENIX lékárenský velkoobchod, s.r.o.
Awardee countryCzech Republic
Awarding agencyInstitut klinické a experimentální medicíny
CountryCzech Republic
Award value$3.9M
Award dateNovember 5, 2024
Last verifiedSeptember 1, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Czech Republic market overview →Browse open opportunities →

Track every Czech Republic contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required